Picking a stock is easy. Managing it as market conditions change and price action shifts is the hard part.
These names are off to good starts to 2023 and could have more room to run.
Getting more absolute value for 70% off the 10-year ago price is an excessively great deal.
Next week Netflix reports and earnings season starts to get in gear.
My tax loss selling recovery strategy is quietly getting the job done. Now let's see what earnings season brings.
Industry experts share their favorite biotech plays for this year.
The market debuts with a bang, ends with a whimper.
There's a basic problem -- we are still in a bear market.
Can a hand-selected group of stocks outperform and entire universe of 'triple nets'?
Potential for the start of significant commercial sales along with the confidence of the insider buyers makes this choice attractive, but don't forget to manage the trade.